Extensible combinatorial CRISPR screening in mammalian cells
Peng Zhou, Yuk Kei Wan, Becky K.C. Chan and 2 more
STAR Protocols · 2021
doi:10.1016/j.xpro.2020.100255 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Summary: The CRISPR-Cas system coupled with Combinatorial Genetics En Masse (CombiGEM) enables systematic analysis of high-order genetic perturbations that are important for understanding biological processes and discovering therapeutic target combinations. Here, we present detailed steps and technical considerations for building multiplexed guide RNA libraries and carrying out a combinatorial CRISPR screen in mammalian cells. We also present an analytical pipeline, CombiPIPE, for mapping two- and three-way genetic interactions.For complete details on the use and execution of this protocol, please refer to Zhou et al. (2020).
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.